The history of Viagra presents a nuanced case for observers in the medicinal sector. While initially a blockbuster success, producing billions, the patent end and the subsequent entry of generic versions have significantly affected revenue. This poses questions about the future sustainability of similar drug innovations and suggests that simply rep